Stay updated on PF-06801591 Dose Escalation in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PF-06801591 Dose Escalation in Solid Tumors Clinical Trial page.

Latest updates to the PF-06801591 Dose Escalation in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded numerous study locations across the US (California, Kentucky, Nevada, New York, North Carolina, Tennessee) and international sites (Pazardzhik; Johor, Kuala Lumpur, Pahang, Sarawak; Leningradskaya Oblast, Sankt-Peterburg; Gyeonggi-do), removed several existing location blocks including US state locations and the HHS Vulnerability Disclosure, and updated the page to revision v3.3.3.SummaryDifference1.0%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedPublication section text updated to indicate that publications are automatically filled from PubMed and may not be about the study, and the revision version updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check46 days agoChange DetectedThe government funding lapse notice and the operating status banner have been removed from the page. Study details and contacts remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedNo significant changes detected in core study content; the page retains all essential information including study details and locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check89 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference1%

- Check97 days agoChange DetectedUpdated software version from v3.0.2 to v3.1.0. This is a version bump indicating an upgrade; no other substantive content changes are evident.SummaryDifference0.0%

Stay in the know with updates to PF-06801591 Dose Escalation in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06801591 Dose Escalation in Solid Tumors Clinical Trial page.